المؤلفون: Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, Goh, Jeffrey C, O'Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Isaacson, Jeff, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A, investigators, ARIEL3, Buck, M, Dean, A, Friedlander, ML, Goh, JC, Harnett, P, Kichenadasse, G, Scott, CL, Denys, H, Dirix, L, Vergote, I, Elit, L, Ghatage, P, Oza, AM, Plante, M, Provencher, D, Weberpals, JI, Welch, S, Floquet, A, Gladieff, L, Joly, F, Leary, A, Lortholary, A, Lotz, J, Medioni, J, Tredan, O, You, B, El-Balat, A, Hänle, C, Krabisch, P, Neunhöffer, T, Pölcher, M, Wimberger, P, Amit, A, Kovel, S, Leviov, M, Safra, T, Shapira-Frommer, R, Stemmer, S, Bologna, A, Colombo, N, Lorusso, D, Pignata, S, Sabbatini, RF, Scambia, G, Tamberi, S, Zamagni, C, Fong, PC, O'Donnell, A, Gancedo, M Amenedo, Herraez, A Casado, Garcia-Donas, J, Guerra, EM, Oaknin, A, Palacio, I, Romero, I, Sanchez, A, Banerjee, SN, Clamp, A, Drew, Y, Gabra, HG, Jackson, D, Ledermann, JA, McNeish, IA, Parkinson, C, Powell, M

المصدر: The Lancet. 390(10106)

مصطلحات موضوعية: Reproductive Medicine, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Orphan Drug, Clinical Research, Cancer, Genetics, Clinical Trials and Supportive Activities, Ovarian Cancer, Rare Diseases, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, Aged, Disease-Free Survival, Double-Blind Method, Female, Follow-Up Studies, Humans, Indoles, Internationality, Maintenance Chemotherapy, Middle Aged, Molecular Targeted Therapy, Neoplasm Recurrence, Local, Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Risk Assessment, Survival Rate, Treatment Outcome, ARIEL3 investigators, Medical and Health Sciences, General & Internal Medicine, Biomedical and clinical sciences, Health sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9xn4w6v7Test

المؤلفون: Jung, M, Gao, J, Cheung, L, Bongers, A, Somers, K, Clifton, M, Ramsay, EE, Russell, AJ, Valli, E, Gifford, AJ, George, J, Kennedy, CJ, Wakefield, MJ, Topp, M, Ho, GY, Scott, CL, Bowtell, DD, deFazio, A, Norris, MD, Haber, M, Henderson, MJ

المصدر: urn:ISSN:0020-7136 ; urn:ISSN:1097-0215 ; International Journal of Cancer, 147, 8, 2225-2238

مصطلحات موضوعية: Cancer, Ovarian Cancer, Rare Diseases, Orphan Drug, 5.1 Pharmaceuticals, 5 Development of treatments and therapeutic interventions, Carcinoma, Endometrioid, Ovarian Epithelial, Cell Line, Tumor, Cell Movement, Cell Proliferation, Cystadenocarcinoma, Serous, Drug Resistance, Neoplasm, Female, Gene Expression Regulation, Neoplastic, Genes, myc, Humans, Multidrug Resistance-Associated Proteins, Ovarian Neoplasms, Prognosis, RNA, Small Interfering, Survival Rate, ABCC4/MRP4

وصف الملف: application/pdf

العلاقة: http://purl.org/au-research/grants/nhmrc/APP1067110Test; http://hdl.handle.net/1959.4/unsworks_80419Test; https://unsworks.unsw.edu.au/bitstreams/cafa378b-e566-4efa-bf72-bbc3cca5523e/downloadTest; https://doi.org/10.1002/ijc.33005Test

الإتاحة: https://doi.org/10.1002/ijc.33005Test
http://hdl.handle.net/1959.4/unsworks_80419Test
https://unsworks.unsw.edu.au/bitstreams/cafa378b-e566-4efa-bf72-bbc3cca5523e/downloadTest

المؤلفون: Swisher, EM, Lin, KK, Oza, AM, Scott, CL, Giordano, H, Sun, J, Konecny, GE, Coleman, RL, Tinker, AV, O'Malley, DM, Kristeleit, RS, Ma, L, Bell-McGuinn, KM, Brenton, JD, Cragun, JM, Oaknin, A, Ray-Coquard, I, Harrell, MI, Mann, E, Kaufmann, SH, Floquet, A, Leary, A, Harding, TC, Goble, S, Maloney, L, Isaacson, J, Allen, AR, Rolfe, L, Yelensky, R, Raponi, M, McNeish, IA

المصدر: Lancet Oncology , 18 (1) pp. 75-87. (2017)

مصطلحات موضوعية: Aged, Antineoplastic Agents, BRCA1 Protein, BRCA2 Protein, Drug Resistance, Neoplasm, Fallopian Tube Neoplasms, Female, Follow-Up Studies, Germ-Line Mutation, Humans, Indoles, International Agencies, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms, Platinum, Poly(ADP-ribose) Polymerase Inhibitors, Poly(ADP-ribose) Polymerases, Prognosis, Prospective Studies, Salvage Therapy, Survival Rate

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10049690/1/Kristeleit_ARIEL2_HRD_Manuscript_Lancet_Oncol_09Sep2016%28clean%29.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10049690Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10049690/1/Kristeleit_ARIEL2_HRD_Manuscript_Lancet_Oncol_09Sep2016%28clean%29.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10049690Test/

المؤلفون: Coleman, RL, Oza, AM, Lorusso, D, Aghajanian, C, Oaknin, A, Dean, A, Colombo, N, Weberpals, JI, Clamp, A, Scambia, G, Leary, A, Holloway, RW, Gancedo, MA, Fong, PC, Goh, JC, O'Malley, DM, Armstrong, DK, Garcia-Donas, J, Swisher, EM, Floquet, A, Konecny, GE, McNeish, IA, Scott, CL, Cameron, T, Maloney, L, Isaacson, J, Goble, S, Grace, C, Harding, TC, Raponi, M, Sun, J, Lin, KK, Giordano, H, Ledermann, JA, ARIEL3 investigators

المساهمون: Leidos Biomedical Research, Inc.

المصدر: 1961 ; 1949

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, EPITHELIAL OVARIAN, SOLID TUMORS, OPEN-LABEL, CANCER, CHEMOTHERAPY, HETEROZYGOSITY, MULTICENTER, BEVACIZUMAB, Aged, Disease-Free Survival, Double-Blind Method, Female, Follow-Up Studies, Humans, Indoles, Internationality, Maintenance Chemotherapy, Middle Aged, Molecular Targeted Therapy, Neoplasm Recurrence, Local, Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Risk Assessment, Survival Rate

العلاقة: Lancet; http://hdl.handle.net/10044/1/53951Test; TCGA Pilot Program; 15Y011ST

الإتاحة: https://doi.org/10.1016/S0140-6736Test(17)32440-6
http://hdl.handle.net/10044/1/53951Test

المؤلفون: Bowtell, DD, Boehm, S, Ahmed, AA, Aspuria, P-J, Bast, RC, Beral, V, Berek, JS, Birrer, MJ, Blagden, S, Bookman, MA, Brenton, JD, Chiappinelli, KB, Martins, FC, Coukos, G, Drapkin, R, Edmondson, R, Fotopoulou, C, Gabra, H, Galon, J, Gourley, C, Heong, V, Huntsman, DG, Iwanicki, M, Karlan, BY, Kaye, A, Lengyel, E, Levine, DA, Lu, KH, McNeish, IA, Menon, U, Narod, SA, Nelson, BH, Nephew, KP, Pharoah, P, Powell, DJ, Ramos, P, Romero, IL, Scott, CL, Sood, AK, Stronach, EA, Balkwill, FR

المصدر: 679 ; 668

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Oncology, BRCA MUTATION CARRIERS, TUBAL-INTRAEPITHELIAL-CARCINOMA, OLAPARIB MAINTENANCE THERAPY, SINGLE-THRESHOLD RULE, HUMAN BREAST-TUMORS, CELL LUNG-CANCER, FALLOPIAN-TUBE, T-CELLS, GERMLINE MUTATIONS, SOMATIC MUTATIONS, Cystadenocarcinoma, Serous, Female, Humans, Neoplasm Grading, Ovarian Neoplasms, Prognosis, Survival Rate, Oncology & Carcinogenesis, 11 Medical And Health Sciences

العلاقة: Nature Reviews Cancer; http://hdl.handle.net/10044/1/43637Test; https://dx.doi.org/10.1038/nrc4019Test

الإتاحة: https://doi.org/10.1038/nrc4019Test
http://hdl.handle.net/10044/1/43637Test